Scan to Download
One power score. Smarter investment decisions
Ventyx Biosciences Inc
VTYX2.300USD
-0.090-3.77%
收盤 09/19, 16:00（美東）報價延遲15分鐘
USD0.000盤後交易 (美東)
163.84M總市值
虧損本益比TTM
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2020Q4
FY2020Q3
營業費用
-17.86%29.33M
-27.94%30.10M
-35.61%32.42M
-33.13%38.55M
-37.51%35.71M
-1.84%41.77M
30.53%50.35M
83.49%57.65M
180.15%57.15M
87.07%42.55M
116.37%38.57M
145.72%31.42M
--20.40M
--22.75M
1137.92%17.83M
472.13%12.79M
--1.44M
--2.23M
研發費用
-19.92%22.27M
-32.15%22.90M
-40.93%24.82M
-38.19%30.63M
-42.74%27.80M
-4.77%33.75M
39.21%42.02M
94.56%49.55M
230.88%48.56M
103.56%35.44M
118.35%30.18M
141.52%25.47M
--14.68M
--17.41M
957.69%13.82M
429.90%10.54M
--1.31M
--1.99M
折舊攤銷及損耗
396.92%323.00K
408.57%356.00K
-21.84%315.00K
836.36%309.00K
91.18%65.00K
125.81%70.00K
776.09%403.00K
3.13%33.00K
41.67%34.00K
47.62%31.00K
187.50%46.00K
255.56%32.00K
--24.00K
--21.00K
--16.00K
--9.00K
--0.00
--0.00
營業利潤
17.86%-29.33M
27.94%-30.10M
35.61%-32.42M
33.13%-38.55M
37.51%-35.71M
1.84%-41.77M
-30.53%-50.35M
-83.49%-57.65M
-180.15%-57.15M
-87.07%-42.55M
-116.37%-38.57M
-145.72%-31.42M
---20.40M
---22.75M
-1137.92%-17.83M
-472.13%-12.79M
---1.44M
---2.23M
淨非營業利息收入（費用）
利息收入
-37.43%2.37M
-17.38%2.67M
-15.60%3.06M
-14.80%3.35M
-2.98%3.78M
-10.91%3.23M
-22.45%3.62M
--3.93M
--3.90M
--3.62M
--4.67M
----
----
----
----
----
----
----
利息費用
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--153.00K
--94.00K
特殊收入（費用）
----
----
----
----
----
----
--0.00
---300.00K
----
----
--0.00
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
---15.11M
---4.83M
-固定資產出售收益
----
----
----
--0.00
--0.00
--800.00K
----
----
----
----
----
----
----
----
----
----
----
----
其他非經營性收入（費用）
0.00%-21.00K
98.92%-9.00K
139.29%11.00K
-487.50%-47.00K
-320.00%-21.00K
-83000.00%-831.00K
97.87%-28.00K
-100.84%-8.00K
-101.32%-5.00K
-106.67%-1.00K
-2362.07%-1.31M
7269.23%958.00K
--380.00K
--15.00K
--58.00K
1400.00%13.00K
--0.00
---1.00K
稅前利潤
15.53%-26.99M
28.86%-27.44M
37.22%-29.35M
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-98.19%-35.21M
-138.47%-30.46M
---20.02M
---22.73M
-6.38%-17.77M
-78.53%-12.77M
---16.70M
---7.16M
除稅後利潤
15.53%-26.99M
28.86%-27.44M
37.22%-29.35M
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-98.19%-35.21M
-138.47%-30.46M
---20.02M
---22.73M
-6.38%-17.77M
-78.53%-12.77M
---16.70M
---7.16M
持續經營利潤
15.53%-26.99M
28.86%-27.44M
37.22%-29.35M
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-98.19%-35.21M
-138.47%-30.46M
---20.02M
---22.73M
-6.38%-17.77M
-78.53%-12.77M
---16.70M
---7.16M
歸属于母公司的淨利潤
15.53%-26.99M
28.86%-27.44M
37.22%-29.35M
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-98.19%-35.21M
-138.47%-30.46M
---20.02M
---22.73M
-6.38%-17.77M
-78.53%-12.77M
---16.70M
---7.16M
優先股派息
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
歸屬普通股東的淨利潤
15.53%-26.99M
28.86%-27.44M
37.22%-29.35M
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-98.19%-35.21M
-138.47%-30.46M
---20.02M
---22.73M
-6.38%-17.77M
-78.53%-12.77M
---16.70M
---7.16M
基本每股收益
16.30%-0.38
38.16%-0.39
47.63%-0.41
45.64%-0.50
50.20%-0.45
7.64%-0.62
-27.57%-0.79
-55.63%-0.92
-131.00%-0.91
-50.30%-0.68
-75.98%-0.62
-125.84%-0.59
---0.39
---0.45
-3.26%-0.35
-78.53%-0.26
---0.34
---0.15
稀釋每股收益
16.30%-0.38
38.16%-0.39
47.63%-0.41
45.64%-0.50
50.20%-0.45
7.64%-0.62
-27.57%-0.79
-55.63%-0.92
-131.00%-0.91
-50.30%-0.68
-75.98%-0.62
-125.84%-0.59
---0.39
---0.45
-3.26%-0.35
-78.53%-0.26
---0.34
---0.15
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
審計意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
